Amgen commits $8m to clinical trial diversity programme
The Robert A. Winn Diversity in Clinical Trials Award Program has been pledged $8 million over the next four years by Amgen.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
